Unconditioned behavioral effects of the powerful kappa-opioid hallucinogen salvinorin A in nonhuman primates: fast onset and entry into cerebrospinal fluid
about
Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disordersNaltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in HumansSalvinorin A administration after global cerebral hypoxia/ischemia preserves cerebrovascular autoregulation via kappa opioid receptor in pigletsThe discriminative effects of the kappa-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects.Studies toward the Development of Antiproliferative Neoclerodanes from Salvinorin A.Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse.Effect of kappa-opioid receptor agonists U69593, U50488H, spiradoline and salvinorin A on cocaine-induced drug-seeking in rats.Learning and memory impairment induced by salvinorin A, the principal ingredient of Salvia divinorum, in wistar rats.Salvinorin A decreases mortality and improves neurological outcome in a neonatal mouse hypoxia modelPharmacology and anti-addiction effects of the novel κ opioid receptor agonist Mesyl Sal B, a potent and long-acting analogue of salvinorin AA single injection of a novel κ opioid receptor agonist salvinorin A attenuates the expression of cocaine-induced behavioral sensitization in rats.Synthesis and biological evaluation of C-2 halogenated analogs of salvinorin A.Behavioral effects and central nervous system levels of the broadly available κ-agonist hallucinogen salvinorin A are affected by P-glycoprotein modulation in vivo.Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET.Salvinorin A and derivatives: protection from metabolism does not prolong short-term, whole-brain residence.LC-MS/MS quantification of salvinorin A from biological fluids.Neurocognitive and neuroinflammatory correlates of PDYN and OPRK1 mRNA expression in the anterior cingulate in postmortem brain of HIV-infected subjects.The 2-methoxy methyl analogue of salvinorin A attenuates cocaine-induced drug seeking and sucrose reinforcements in rats.New therapeutic potential for psychoactive natural products.Salvia divinorum: from Mazatec medicinal and hallucinogenic plant to emerging recreational drug.Novel neoclerodane diterpene derivatives from the smoke of salvinorin A.The C-2 derivatives of salvinorin A, ethoxymethyl ether Sal B and β-tetrahydropyran Sal B, have anti-cocaine properties with minimal side effects.The analgesic and anti-inflammatory effects of Salvinorin A analogue β-tetrahydropyran Salvinorin B in mice.Structurally-Related Kappa Opioid Receptor Agonists with Substantial Differential Signaling Bias: Neuroendocrine and Behavioral Effects in C57BL6 Mice.
P2860
Q26781580-7917B585-4B4F-4D76-B257-137CCEECA0E4Q27300685-9836E164-C623-4132-902A-0FF00191C656Q28481482-907E49B2-5A4B-4E36-AA12-1A8E59F28A36Q33835281-1D4672CE-956F-4B7E-BCCE-FA1CD5C2E867Q34083438-02E4BB36-8003-4264-BE87-BBE93215438DQ34401390-CA3EA30F-D3F6-403B-889F-06FCE7469602Q34493780-2D591B34-4F92-4905-A792-6E07B6C5A332Q34632744-0592F566-276A-48F8-8714-1A9843C5A382Q34820974-3866DBBA-2872-4DF2-80FC-C97EE791580FQ34939810-B7C375C7-3565-4A79-863A-C4A8CFBD60E3Q35837572-78A0B34C-5FBA-4F8E-B14A-80EC0764C533Q35887833-2F9E2413-0E0C-4A98-90B6-5128029F0F1FQ35996706-3F039C42-FAC0-499B-AAFE-41B6D33F248DQ36894509-64FB9FC1-F1BE-4CA1-8B47-9A8EA94243A2Q37349384-21DC1E18-788F-4B28-8A9B-D2CC6E22C5E8Q37451366-B7FB9793-3324-485B-8272-5D7C3482D8DAQ37496856-A2911C76-983B-4173-9286-28C82E8CA7FBQ37507887-8B1370C3-A0C5-4F69-A515-94270B7FA634Q37660087-07D694AF-9CE1-49D0-9448-561CC6C49366Q38116484-EE1EDDF0-5D9B-4565-9824-8AA521B87466Q42286399-75FFAC40-C484-4B4A-998A-19600B392CF7Q47878237-699A1610-1512-4653-AECA-212E9F894D69Q47977698-79733609-BCB4-4705-8E85-8DF6146F37BBQ52317568-ACA491F9-E934-43C3-B52B-BB73742A502B
P2860
Unconditioned behavioral effects of the powerful kappa-opioid hallucinogen salvinorin A in nonhuman primates: fast onset and entry into cerebrospinal fluid
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Unconditioned behavioral effec ...... entry into cerebrospinal fluid
@en
Unconditioned behavioral effec ...... ntry into cerebrospinal fluid.
@nl
type
label
Unconditioned behavioral effec ...... entry into cerebrospinal fluid
@en
Unconditioned behavioral effec ...... ntry into cerebrospinal fluid.
@nl
prefLabel
Unconditioned behavioral effec ...... entry into cerebrospinal fluid
@en
Unconditioned behavioral effec ...... ntry into cerebrospinal fluid.
@nl
P2093
P2860
P356
P1476
Unconditioned behavioral effec ...... entry into cerebrospinal fluid
@en
P2093
Eduardo R Butelman
Haiteng Deng
Szymon Rus
Thomas E Prisinzano
P2860
P304
P356
10.1124/JPET.108.145342
P407
P577
2008-11-10T00:00:00Z